NO20080665L - Fag-fremvisning i a benytte kontraslasjonell translokasjon av fusjonspolypeptider - Google Patents

Fag-fremvisning i a benytte kontraslasjonell translokasjon av fusjonspolypeptider

Info

Publication number
NO20080665L
NO20080665L NO20080665A NO20080665A NO20080665L NO 20080665 L NO20080665 L NO 20080665L NO 20080665 A NO20080665 A NO 20080665A NO 20080665 A NO20080665 A NO 20080665A NO 20080665 L NO20080665 L NO 20080665L
Authority
NO
Norway
Prior art keywords
phage
translocation
polypeptides
phage display
contralateral
Prior art date
Application number
NO20080665A
Other languages
English (en)
Inventor
Daniel Steiner
Patrik Forrer
Michael T Stumpp
Andreas Plueckthun
Original Assignee
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Zuerich filed Critical Univ Zuerich
Publication of NO20080665L publication Critical patent/NO20080665L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors

Abstract

Den foreliggende oppfinnelse er relatert til en fremgangsmåte av filamentøs fagfremvisning for polypeptidene av interesse fremvist på fagpartikkelen er kotranslasjonell translokert over den cytoplasmiske membranen av gramnegative bakterier basert på signalgjenkjermings partikkelvelen. Derme fremgangsmåten er spesielt egnet for polypeptider, som er kjent til å være vanskelig å fremvise på fag, og for proteiner av cDNA bibliotek og andre kombinasjonsmessige bibliotek, spesielt når derivert fiia veldig raskt foldende, stabile proteinskaffblder. Oppfirmelsen er videre relatert til fag eller fagmidvektorer nyttige i fremgangsmåten omfattende en genkonstruksjon kodende for et fusjonspolypeptid omfattende polypeptidet som skal bli fremvist på fagpartikkelen og en N-terminal signalsekvens som fremmer kotranslasjonell translokasjon.
NO20080665A 2005-07-08 2008-02-05 Fag-fremvisning i a benytte kontraslasjonell translokasjon av fusjonspolypeptider NO20080665L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05106236 2005-07-08
PCT/EP2006/063729 WO2007006665A1 (en) 2005-07-08 2006-06-30 Phage display using cotranslational translocation of fusion polypeptides

Publications (1)

Publication Number Publication Date
NO20080665L true NO20080665L (no) 2008-02-05

Family

ID=35063135

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080665A NO20080665L (no) 2005-07-08 2008-02-05 Fag-fremvisning i a benytte kontraslasjonell translokasjon av fusjonspolypeptider

Country Status (21)

Country Link
US (2) US8846577B2 (no)
EP (1) EP1902131B1 (no)
JP (1) JP5042218B2 (no)
KR (1) KR101268939B1 (no)
CN (1) CN101213299B (no)
AT (1) ATE448305T1 (no)
AU (1) AU2006268780B2 (no)
BR (1) BRPI0613593A2 (no)
CA (1) CA2614512C (no)
DE (1) DE602006010386D1 (no)
DK (1) DK1902131T3 (no)
ES (1) ES2335136T3 (no)
HK (1) HK1122839A1 (no)
IL (1) IL188518A (no)
MX (1) MX2008000345A (no)
NO (1) NO20080665L (no)
NZ (1) NZ564695A (no)
PL (1) PL1902131T3 (no)
RU (1) RU2412249C2 (no)
WO (1) WO2007006665A1 (no)
ZA (1) ZA200710687B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2490280A1 (en) 2002-07-01 2004-01-08 Human Genome Sciences, Inc. Antibodies that specifically bind to reg iv
US7618799B2 (en) * 2007-01-31 2009-11-17 Dow Global Technologies Inc Bacterial leader sequences for increased expression
WO2010060748A1 (en) 2008-11-03 2010-06-03 Molecular Partners Ag Binding proteins inhibiting the vegf-a receptor interaction
GB0917647D0 (en) * 2009-10-08 2009-11-25 Glaxosmithkline Biolog Sa Expression system
EP2496601B1 (en) * 2009-11-05 2017-06-07 F. Hoffmann-La Roche AG Methods and composition for secretion of heterologous polypeptides
AR081361A1 (es) 2010-04-30 2012-08-29 Molecular Partners Ag Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a
ES2758352T3 (es) 2010-11-26 2020-05-05 Molecular Partners Ag Proteínas de repetición diseñadas que se une a la seroalbúmina
RU2748733C2 (ru) 2011-02-15 2021-05-31 Иммуноджен, Инк. Цитотоксические производные бензодиазепина
TW201302779A (zh) * 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗
AU2012249359A1 (en) 2011-04-29 2013-11-14 Janssen Biotech, Inc. IL4/IL13 binding repeat proteins and uses
US9289512B2 (en) 2011-06-21 2016-03-22 Immunogen, Inc. Maytansinoid derivatives with peptide linker and conjugates thereof
AU2013283296A1 (en) 2012-06-28 2015-02-05 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
US9956341B2 (en) 2012-07-03 2018-05-01 Milestone Scientific, Inc. Drug infusion with pressure sensing and non-continuous flow for identification of and injection into fluid-filled anatomic spaces
EP2887965A1 (en) 2012-08-22 2015-07-01 ImmunoGen, Inc. Cytotoxic benzodiazepine derivatives
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
JP6423804B2 (ja) 2013-02-28 2018-11-14 イミュノジェン・インコーポレーテッド 細胞結合剤及び細胞毒性剤を含む複合体
EP2961434A2 (en) 2013-02-28 2016-01-06 ImmunoGen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
WO2014194030A2 (en) 2013-05-31 2014-12-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
EP3004152B1 (en) 2013-05-31 2020-09-30 Molecular Partners AG Designed ankyrin repeat proteins binding to hepatocyte growth factor
CA2941687A1 (en) 2014-03-14 2015-09-17 Genentech, Inc. Methods and compositions for secretion of heterologous polypeptides
RU2016141385A (ru) 2014-03-24 2018-04-28 Дженентек, Инк. Лечение рака антагонистами с-мет и их корреляция с экспрессией hgf
WO2016036804A1 (en) 2014-09-03 2016-03-10 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
TWI697493B (zh) 2014-09-03 2020-07-01 美商免疫原公司 細胞毒性苯并二氮呯衍生物
BR112017020986A2 (pt) 2015-04-02 2018-08-14 Molecular Partners Ag. proteínas de ligação recombinantes e seu uso
US10220180B2 (en) 2015-10-16 2019-03-05 Milestone Scientific, Inc. Method and apparatus for performing a peripheral nerve block
MA46111A (fr) 2016-08-31 2019-07-10 Harvard College Bactéries génétiquement modifiées sécrétant des protéines thérapeutiques et procédés d'utilisation de celles-ci
US10717772B2 (en) 2016-09-22 2020-07-21 Molecular Partners Ag Recombinant binding proteins targeting HER2 and serum albumin, and their uses
US10632255B2 (en) 2017-02-15 2020-04-28 Milestone Scientific, Inc. Drug infusion device
CN116785450A (zh) 2017-02-28 2023-09-22 伊缪诺金公司 具有自分解肽接头的类美登素衍生物和其缀合物
TW201839001A (zh) 2017-04-20 2018-11-01 美商伊繆諾金公司 細胞毒性苯并二氮平衍生物及其綴合物
US11471595B2 (en) 2017-05-04 2022-10-18 Milestone Scientific, Inc. Method and apparatus for performing a peripheral nerve block
WO2019133652A1 (en) 2017-12-28 2019-07-04 Immunogen, Inc. Benzodiazepine derivatives
CN113631194A (zh) 2019-03-21 2021-11-09 伊缪诺金公司 制备细胞结合剂-药物缀合物的方法
JP2022529583A (ja) 2019-03-29 2022-06-23 イミュノジェン・インコーポレーテッド 異常細胞増殖を阻害するまたは増殖性疾患を治療するための細胞毒性ビス－ベンゾジアゼピン誘導体及び細胞結合剤とのその複合体
FI3958977T3 (fi) 2019-04-26 2023-12-12 Immunogen Inc Kamptotesiinijohdannaisia
US10646660B1 (en) 2019-05-16 2020-05-12 Milestone Scientific, Inc. Device and method for identification of a target region
MX2022007122A (es) 2019-12-11 2022-09-09 Molecular Partners Ag Dominios de repetición de anquirina diseñados con residuos de superficie alterados.
CA3176845A1 (en) 2020-05-06 2021-11-11 Patrick AMSTUTZ Novel ankyrin repeat binding proteins and their uses
WO2022190016A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based multi-specific t-cell engagers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078051B1 (en) 1998-05-13 2007-12-12 Domantis Limited Phage-display system for the selection of correctly folded proteins

Also Published As

Publication number Publication date
WO2007006665A1 (en) 2007-01-18
ATE448305T1 (de) 2009-11-15
KR101268939B1 (ko) 2013-05-30
RU2008104174A (ru) 2009-08-20
US9447142B2 (en) 2016-09-20
JP5042218B2 (ja) 2012-10-03
US20110118146A1 (en) 2011-05-19
AU2006268780B2 (en) 2011-03-24
MX2008000345A (es) 2008-04-02
DE602006010386D1 (en) 2009-12-24
PL1902131T3 (pl) 2010-05-31
RU2412249C2 (ru) 2011-02-20
DK1902131T3 (da) 2010-03-01
ES2335136T3 (es) 2010-03-22
KR20080035603A (ko) 2008-04-23
EP1902131A1 (en) 2008-03-26
ZA200710687B (en) 2008-11-26
US8846577B2 (en) 2014-09-30
EP1902131B1 (en) 2009-11-11
AU2006268780A1 (en) 2007-01-18
CN101213299A (zh) 2008-07-02
IL188518A0 (en) 2008-04-13
JP2009500027A (ja) 2009-01-08
HK1122839A1 (en) 2009-05-29
BRPI0613593A2 (pt) 2011-01-18
IL188518A (en) 2011-04-28
NZ564695A (en) 2009-02-28
CA2614512C (en) 2014-01-07
CA2614512A1 (en) 2007-01-18
US20150057186A1 (en) 2015-02-26
CN101213299B (zh) 2013-03-27

Similar Documents

Publication Publication Date Title
NO20080665L (no) Fag-fremvisning i a benytte kontraslasjonell translokasjon av fusjonspolypeptider
Baeumler et al. Engineering synthetic signaling pathways with programmable dCas9-based chimeric receptors
JP2009500027A5 (no)
US8592179B2 (en) Artificial binding proteins based on a modified alpha helical region of ubiquitin
Huesgen et al. N‐and C‐terminal degradomics: new approaches to reveal biological roles for plant proteases from substrate identification
DE60211329D1 (de) Isolierung von sezernierte proteine exprimierenden zellen
DE60138764D1 (de) Methode zur identifikation und isolation von peptide die andere moleküle binden aus kombinatorische proteinbibliotheken mit einer c-typ lectin-ähnlichen domäne als gerüststruktur
JP2011201893A (ja) ユビキチンタンパク質に基づく人工結合タンパク質の生成
Jeong et al. APEx 2-hybrid, a quantitative protein–protein interaction assay for antibody discovery and engineering
Bowen et al. Screening of yeast display libraries of enzymatically treated peptides to discover macrocyclic peptide ligands
Souriau et al. New binding specificities derived from Min-23, a small cystine-stabilized peptidic scaffold
Bosma et al. Genetically encoded libraries of constrained peptides
Arbulu et al. Cloning and expression of synthetic genes encoding native, hybrid-and bacteriocin-derived chimeras from mature class IIa bacteriocins, by Pichia pastoris (syn. Komagataella spp.)
Waraho et al. Versatile selection technology for intracellular protein–protein interactions mediated by a unique bacterial hitchhiker transport mechanism
Zhang et al. Sortase A‐mediated synthesis of ligand‐grafted cyclized peptides for modulating a model protein‐protein interaction
Tresnak et al. Deep antimicrobial activity and stability analysis inform lysin sequence–function mapping
Ju et al. Evolution of Src Homology 2 (SH2) domain to recognize sulfotyrosine
Fouët et al. Molecular basis of complement C1q collagen-like region interaction with the immunoglobulin-like receptor LAIR-1
WO2011086116A1 (en) Method for identifying an inhibitors of protein translocation
GB201102700D0 (en) Protein secretion
Frisch et al. From EST to IHC: human antibody pipeline for target research
Nangola et al. Appraisal of translocation pathways for displaying ankyrin repeat protein on phage particles
WO2006089801A3 (de) Verfahren zum redox-potential-abhängigen nachweis von targetmolekülen durch wechselwirkende polypeptide
Christ et al. Identification of protein domains by shotgun proteolysis
Veggiani et al. Peptides meet ubiquitin: Simple interactions regulating complex cell signaling

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application